287 related articles for article (PubMed ID: 30086056)
41. Common MUTYH mutations and colorectal cancer risk in multiethnic populations.
Lejbkowicz F; Cohen I; Barnett-Griness O; Pinchev M; Poynter J; Gruber SB; Rennert G
Fam Cancer; 2012 Sep; 11(3):329-35. PubMed ID: 22371070
[TBL] [Abstract][Full Text] [Related]
42. Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.
Vande Perre P; Siegfried A; Corsini C; Bonnet D; Toulas C; Hamzaoui N; Selves J; Chipoulet E; Hoffmann JS; Uro-Coste E; Guimbaud R
Fam Cancer; 2019 Apr; 18(2):173-178. PubMed ID: 30368636
[TBL] [Abstract][Full Text] [Related]
43. Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families.
Weber CAM; Krönke N; Volk V; Auber B; Förster A; Trost D; Geffers R; Esmaeilzadeh M; Lalk M; Nabavi A; Samii A; Krauss JK; Feuerhake F; Hartmann C; Wiese B; Brand F; Weber RG
Acta Neuropathol Commun; 2023 Nov; 11(1):184. PubMed ID: 37990341
[TBL] [Abstract][Full Text] [Related]
44. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
45. POLE somatic mutations in advanced colorectal cancer.
Guerra J; Pinto C; Pinto D; Pinheiro M; Silva R; Peixoto A; Rocha P; Veiga I; Santos C; Santos R; Cabreira V; Lopes P; Henrique R; Teixeira MR
Cancer Med; 2017 Dec; 6(12):2966-2971. PubMed ID: 29072370
[TBL] [Abstract][Full Text] [Related]
46. Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns.
Hu H; Cai W; Wu D; Hu W; Dong Wang L; Mao J; Zheng S; Ge W
Cancer Med; 2021 Jan; 10(1):135-142. PubMed ID: 33125191
[TBL] [Abstract][Full Text] [Related]
47. Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study.
El Hachem N; Abadie C; Longy M; Colas C; Fert-Ferrer S; Leroux D; Grandval P; Prieur F; Collonge-Rame M; Faivre L; Fricker JP; Zerbib F; Coupier I; Cauchin E; Pinson S; Saurin JC
Dis Colon Rectum; 2019 Apr; 62(4):470-475. PubMed ID: 30640315
[TBL] [Abstract][Full Text] [Related]
48. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract][Full Text] [Related]
49. Characterization of a novel POLD1 missense founder mutation in a Spanish population.
Ferrer-Avargues R; Díez-Obrero V; Martín-Tomás E; Hernández-Illán E; Castillejo MI; Codoñer-Alejos A; Barberá VM; Sánchez-Heras AB; Segura Á; Juan MJ; Tena I; Castillejo A; Soto JL
J Gene Med; 2017 Apr; 19(4):. PubMed ID: 28306219
[TBL] [Abstract][Full Text] [Related]
50. POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.
Chen YX; Wang ZX; Yuan SQ; Jiang TJ; Huang YS; Xu RH; Wang F; Zhao Q
Clin Transl Med; 2021 Sep; 11(9):e524. PubMed ID: 34586735
[No Abstract] [Full Text] [Related]
51. Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.
Kawai T; Nyuya A; Mori Y; Tanaka T; Tanioka H; Yasui K; Toshima T; Taniguchi F; Shigeyasu K; Umeda Y; Fujiwara T; Okawaki M; Yamaguchi Y; Goel A; Nagasaka T
Clin Epigenetics; 2021 May; 13(1):117. PubMed ID: 34034807
[TBL] [Abstract][Full Text] [Related]
52. Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer.
Yoshida R; Miyashita K; Inoue M; Shimamoto A; Yan Z; Egashira A; Oki E; Kakeji Y; Oda S; Maehara Y
Eur J Hum Genet; 2011 Mar; 19(3):320-5. PubMed ID: 21157497
[TBL] [Abstract][Full Text] [Related]
53. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.
Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I
J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063
[TBL] [Abstract][Full Text] [Related]
54. Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction.
Hamzaoui N; Alarcon F; Leulliot N; Guimbaud R; Buecher B; Colas C; Corsini C; Nuel G; Terris B; Laurent-Puig P; Chaussade S; Dhooge M; Madru C; Clauser E
Genet Med; 2020 Sep; 22(9):1533-1541. PubMed ID: 32424176
[TBL] [Abstract][Full Text] [Related]
55. The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded material.
Jansen AML; Tops CMJ; Ruano D; van Eijk R; Wijnen JT; Ten Broeke S; Nielsen M; Hes FJ; van Wezel T; Morreau H
Eur J Hum Genet; 2020 Mar; 28(3):333-338. PubMed ID: 31616036
[TBL] [Abstract][Full Text] [Related]
56. A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine.
Hansen MF; Johansen J; Bjørnevoll I; Sylvander AE; Steinsbekk KS; Sætrom P; Sandvik AK; Drabløs F; Sjursen W
Fam Cancer; 2015 Sep; 14(3):437-48. PubMed ID: 25860647
[TBL] [Abstract][Full Text] [Related]
57. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
58. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
[TBL] [Abstract][Full Text] [Related]
59. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
[TBL] [Abstract][Full Text] [Related]
60. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors.
Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
